• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR362-3p 通过调控 IL6ST/JAK2/STAT3 通路缓解骨肉瘤 及其相关机制的研究

MiR362-3p Alleviates Osteosarcoma by Regulating the IL6ST/JAK2/STAT3 Pathway and .

机构信息

Department of Spine Surgery, Zhujiang Hosptial, Southern Medical University, Guangzhou, China.

Department of Rehabilitation Medicine, The First Affiliated Hospital of Gannan Medical College, Ganzhou, China.

出版信息

Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241261616. doi: 10.1177/15330338241261616.

DOI:10.1177/15330338241261616
PMID:39051528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11273602/
Abstract

To investigate the effects and the related signaling pathway of miR-362-3p on OS. The bioinformatics analysis approaches were employed to investigate the target pathway of miR-362-3p. After the 143B and U2OS cells and nu/nu male mice were randomly divided into blank control (BC) group, normal control (NC) group, and overexpression group (OG), the CCK-8, EdU staining, wound healing assay, Transwell assay, and TUNEL staining were adopted to respectively determine the effects of overexpressed miR-362-3p on the cell viability, proliferation, migration, invasion, and apoptosis of 143B and U2OS cells , tumor area assay and hematoxylin and eosin staining were employed to respectively determine the effects of overexpressed miR-362-3p on the growth and pathological injury of OS tissue . The qRT-PCR, Western blot, and immunohistochemical staining were applied to respectively investigate the effects of overexpressed miR-362-3p on the IL6ST/JAK2/STAT3 pathway in OS and . The bioinformatics analysis approaches combined qRT-PCR indicated that the IL6ST/JAK2/STAT3 is one of the target pathways of miR-362-3p. Compared with NC, the cell viability, proliferation, migration, and invasion of 143B and U2OS cells were dramatically (< 0.01) inhibited but the apoptosis was prominently (<0 .0001) promoted in OG. Compared with NC, the growth of OS tissue was significantly (< 0.05) suppressed and the pathological injury of OS tissue was substantially aggravated in OG. The gene expression levels of IL6ST, JAK2, and STAT3 and the protein expression levels of IL6ST, JAK2, p-JAK2, STAT3, and p-STAT3 in 143B and U2OS cells were memorably (< 0.0001) lower in OG than those in NC. In addition, the positively stained areas of proteins of IL6ST, JAK2, p-JAK2, STAT3, and p-STAT3 of OS tissue in OG were markedly (< 0.01) reduced compared with those in NC. The overexpression of miR362-3p alleviates OS by inhibiting the IL6ST/JAK2/STAT3 pathway and .

摘要

探讨 miR-362-3p 对骨肉瘤(OS)的影响及其相关信号通路。采用生物信息学分析方法探讨 miR-362-3p 的靶通路。将 143B 和 U2OS 细胞及裸鼠分为空白对照组(BC 组)、正常对照组(NC 组)和过表达组(OG 组),采用 CCK-8、EdU 染色、划痕愈合实验、Transwell 实验和 TUNEL 染色分别检测过表达 miR-362-3p 对 143B 和 U2OS 细胞活力、增殖、迁移、侵袭和凋亡的影响,采用肿瘤面积检测和苏木精-伊红(H&E)染色分别检测过表达 miR-362-3p 对 OS 组织生长和病理损伤的影响,采用 qRT-PCR、Western blot 和免疫组化染色分别检测过表达 miR-362-3p 对 OS 中 IL6ST/JAK2/STAT3 通路的影响。生物信息学分析联合 qRT-PCR 表明,IL6ST/JAK2/STAT3 是 miR-362-3p 的靶通路之一。与 NC 组相比,OG 组 143B 和 U2OS 细胞活力、增殖、迁移和侵袭显著(<0.01)下降,凋亡明显(<0.0001)增加。与 NC 组相比,OG 组 OS 组织生长明显(<0.05)受抑制,OS 组织病理损伤显著加重。与 NC 组相比,OG 组 143B 和 U2OS 细胞中 IL6ST、JAK2、STAT3 基因表达水平及 IL6ST、JAK2、p-JAK2、STAT3、p-STAT3 蛋白表达水平均显著(<0.0001)降低。此外,OG 组 OS 组织中 IL6ST、JAK2、p-JAK2、STAT3 和 p-STAT3 蛋白阳性染色面积均明显(<0.01)低于 NC 组。过表达 miR362-3p 通过抑制 IL6ST/JAK2/STAT3 通路减轻 OS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/f6f2f7a0f454/10.1177_15330338241261616-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/fcb488abeb74/10.1177_15330338241261616-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/7c6d03f19ffc/10.1177_15330338241261616-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/67c51aa0c93a/10.1177_15330338241261616-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/bbfbe0584467/10.1177_15330338241261616-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/3f6850c9e82a/10.1177_15330338241261616-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/4295af67a92e/10.1177_15330338241261616-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/04d5a21c1522/10.1177_15330338241261616-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/fb2c9081d351/10.1177_15330338241261616-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/4e48608f513a/10.1177_15330338241261616-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/c1f245a70504/10.1177_15330338241261616-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/f6f2f7a0f454/10.1177_15330338241261616-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/fcb488abeb74/10.1177_15330338241261616-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/7c6d03f19ffc/10.1177_15330338241261616-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/67c51aa0c93a/10.1177_15330338241261616-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/bbfbe0584467/10.1177_15330338241261616-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/3f6850c9e82a/10.1177_15330338241261616-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/4295af67a92e/10.1177_15330338241261616-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/04d5a21c1522/10.1177_15330338241261616-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/fb2c9081d351/10.1177_15330338241261616-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/4e48608f513a/10.1177_15330338241261616-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/c1f245a70504/10.1177_15330338241261616-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a83a/11273602/f6f2f7a0f454/10.1177_15330338241261616-fig11.jpg

相似文献

1
MiR362-3p Alleviates Osteosarcoma by Regulating the IL6ST/JAK2/STAT3 Pathway and .miR362-3p 通过调控 IL6ST/JAK2/STAT3 通路缓解骨肉瘤 及其相关机制的研究
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241261616. doi: 10.1177/15330338241261616.
2
ADRB2 is regulated by TRIM22 and facilitates lung adenocarcinoma progression via JAK2/STAT3 signaling pathway.β2肾上腺素能受体(ADRB2)受TRIM22调控,并通过JAK2/STAT3信号通路促进肺腺癌进展。
Sci Rep. 2025 Jul 1;15(1):22083. doi: 10.1038/s41598-025-06017-6.
3
miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.M2 极化肿瘤相关巨噬细胞来源的 exosomes 中的 miRNA-221-3p 通过 SOCS3/JAK2/STAT3 轴加重骨肉瘤的生长和转移。
Aging (Albany NY). 2021 Aug 13;13(15):19760-19775. doi: 10.18632/aging.203388.
4
miRNA-548d-3p represses non-small cell lung cancer growth by perturbing DDX5-mediated pyroptosis through JAK2/STAT3 signaling.微小RNA-548d-3p通过JAK2/STAT3信号通路干扰DDX5介导的细胞焦亡来抑制非小细胞肺癌的生长。
Cell Signal. 2025 Jun 15;134:111945. doi: 10.1016/j.cellsig.2025.111945.
5
[Exploration of the mechanism of electroacupuncture at "Jiaji" (EX-B2) in treating neuronal apoptosis in rats with spinal cord injury based on the JAK2/STAT3 pathway].基于JAK2/STAT3通路探讨电针“夹脊”(EX - B2)治疗脊髓损伤大鼠神经元凋亡的机制
Zhen Ci Yan Jiu. 2025 Jun 25;50(6):633-640. doi: 10.13702/j.1000-0607.20240070.
6
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.小窝蛋白-1通过表皮生长因子受体(EGFR)降解抑制肺腺癌的增殖和侵袭。
Sci Rep. 2025 Jul 1;15(1):21654. doi: 10.1038/s41598-025-05259-8.
7
Rab27aCAF exosomal miR-9-5p promotes osteosarcoma progression via CREBRF/MAPK signaling pathway.Rab27aCAF外泌体miR-9-5p通过CREBRF/MAPK信号通路促进骨肉瘤进展。
Cell Signal. 2025 Oct;134:111964. doi: 10.1016/j.cellsig.2025.111964. Epub 2025 Jun 26.
8
Targeting nerve growth factor-mediated osteosarcoma metastasis: mechanistic insights and therapeutic opportunities using larotrectinib.靶向神经生长因子介导的骨肉瘤转移:使用拉罗替尼的机制见解和治疗机会。
Cell Death Dis. 2024 May 30;15(5):381. doi: 10.1038/s41419-024-06752-0.
9
miRNA-223-3p regulates ECT2 to promote proliferation, invasion, and metastasis of gastric cancer through the Wnt/β-catenin signaling pathway.微小RNA-223-3p通过Wnt/β-连环蛋白信号通路调节ECT2,以促进胃癌的增殖、侵袭和转移。
J Cancer Res Clin Oncol. 2023 Jan;149(1):121-134. doi: 10.1007/s00432-022-04453-9. Epub 2022 Nov 10.
10
Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression.长非编码 RNA TUG1 通过增强 ZBTB7C 表达促进骨肉瘤的恶性进展。
Biomed J. 2024 Jun;47(3):100651. doi: 10.1016/j.bj.2023.100651. Epub 2023 Aug 9.

引用本文的文献

1
The emerging role of miR-362 in cancer: expression and function across different cancer types.miR-362在癌症中的新作用:不同癌症类型中的表达与功能
Med Oncol. 2025 Jul 26;42(9):380. doi: 10.1007/s12032-025-02900-4.

本文引用的文献

1
Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1.外泌体介导的 miR-144-3p 通过调节 ZEB1 促进铁死亡抑制骨肉瘤增殖、迁移和侵袭。
Mol Cancer. 2023 Jul 17;22(1):113. doi: 10.1186/s12943-023-01804-z.
2
MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis.MicroRNA-324-3p 通过抑制 PGAM1 介导的有氧糖酵解抑制骨肉瘤的进展。
Cancer Sci. 2023 Jun;114(6):2345-2359. doi: 10.1111/cas.15779. Epub 2023 Mar 21.
3
Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway.
Telocinobufagin 通过抑制 JAK2/STAT3 信号通路抑制骨肉瘤的生长和转移。
Eur J Pharmacol. 2023 Mar 5;942:175529. doi: 10.1016/j.ejphar.2023.175529. Epub 2023 Jan 20.
4
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.JAK-STAT 信号通路在炎症性乳腺癌中可使化疗耐药细胞状态。
Cancer Res. 2023 Jan 18;83(2):264-284. doi: 10.1158/0008-5472.CAN-22-0423.
5
Cinobufagin inhibits tumor progression and reduces doxorubicin resistance by enhancing FOXO1-mediated transcription of FCGBP in osteosarcoma.华蟾素通过增强 FOXO1 介导的 FCGBP 在骨肉瘤中的转录来抑制肿瘤进展和降低多柔比星耐药性。
J Ethnopharmacol. 2022 Oct 5;296:115433. doi: 10.1016/j.jep.2022.115433. Epub 2022 Jun 8.
6
MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity.微小 RNA 与骨肉瘤:抑制转移和增加化疗敏感性的潜在靶点。
Biochem Pharmacol. 2022 Jul;201:115094. doi: 10.1016/j.bcp.2022.115094. Epub 2022 May 16.
7
BMI1 promotes osteosarcoma proliferation and metastasis by repressing the transcription of SIK1.BMI1通过抑制SIK1的转录促进骨肉瘤的增殖和转移。
Cancer Cell Int. 2022 Mar 27;22(1):136. doi: 10.1186/s12935-022-02552-8.
8
Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.miR-362-3p/miR-425-5p 下调 ZC3H13 的表达与肝癌患者预后不良及不良结局相关。
Aging (Albany NY). 2022 Mar 12;14(5):2304-2319. doi: 10.18632/aging.203939.
9
miR-362-3p suppresses ovarian cancer by inhibiting LRP8.微小RNA-362-3p通过抑制低密度脂蛋白受体相关蛋白8来抑制卵巢癌。
Transl Oncol. 2022 Jan;15(1):101284. doi: 10.1016/j.tranon.2021.101284. Epub 2021 Nov 26.
10
The JAK/STAT signaling pathway: from bench to clinic.JAK/STAT 信号通路:从基础到临床。
Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1.